Abstract
IntroductionMineralocorticoid receptor antagonists (MRAs) reduce mortality and morbidity in patients with heart failure and reduced ejection fraction (HFrEF), but are largely underused. We evaluated the frequency, motives, predictors and outcomes...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have